Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.68 |
| ▸ | MAPT | P10636 | 7/20 | 0.68 |
| ▸ | HPGD | P15428 | 6/20 | 0.68 |
| ▸ | TP53 | P04637 | 6/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | BCHE | P06276 | 4/20 | 0.68 |
| ▸ | ACHE | P22303 | 4/20 | 0.68 |
| ▸ | XDH | P47989 | 4/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28430943 | 0.87 | TP53 (0.60) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL471861 | 0.87 | MEN1 (0.71) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL4879748 | 0.85 | AMY1A (0.78) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| 6-Hydroxykaempferol SCHEMBL674949 | 0.84 | AMY1A (0.76) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| 6-Hydroxykaempferol SCHEMBL29725747 | 0.84 | AMY1A (0.76) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL8749579 | 0.83 | MAOA (0.70) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL29569956 | 0.83 | MEN1 (0.71) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL10335363 | 0.82 | MEN1 (0.79) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| Kaempferol SCHEMBL1259228 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| Kaempferol SCHEMBL29378805 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117987-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2021-09-14 | — | — | US | disclosed |
| US-11028195-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2021-06-08 | — | — | US | disclosed |
| US-20190322777-A1 | Hydroxyaryl Functionalized Polymers | BRIDGESTONE CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
| US-10370475-B2 | Elastomeric compounds having increased cold flow resistance and methods producing the same | BRIDGESTONE CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20190233557-A1 | Hydroxyaryl Functionalized Polymers | BRIDGESTONE CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-10227425-B2 | Hydroxyaryl functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2019-03-12 | — | — | US | disclosed |
| CN-104478897-A | Oxazino-scutellarin aglycone derivative as well as preparation method and application thereof | UNIV NANJING CHINESE MEDICINE | 2015-04-01 | — | — | CN | disclosed |
| CN-102702155-B | Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product | UNIV NANJING CHINESE MEDICINE | 2014-05-07 | — | — | CN | disclosed |
| CN-102702155-A | Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product | UNIV NANJING CHINESE MEDICINE | 2012-10-03 | — | — | CN | disclosed |
| CN-102690308-A | Scutellarin-7-glycosyl derivatives, and preparation method and application thereof | UNIV NANJING CHINESE MEDICINE | 2012-09-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322777-A1 | Hydroxyaryl Functionalized Polymers | HAAO, HCAR3, VCL | MEN1 4721/4885KMT2A 1705/4885CYP3A4 25/4885 |
| US-11028195-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | MEN1 4769/4885KMT2A 1828/4885CYP3A4 30/4885 |
| US-10227425-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | MEN1 4721/4885KMT2A 1705/4885CYP3A4 25/4885 |
| US-11117987-B2 | Hydroxyaryl functionalized polymers | HAAO, HCAR3, VCL | MEN1 4721/4885KMT2A 1705/4885CYP3A4 25/4885 |
| US-20190233557-A1 | Hydroxyaryl Functionalized Polymers | HAAO, HCAR3, VCL | MEN1 4769/4885KMT2A 1828/4885CYP3A4 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.